BeOne Medicines officer proposes $632K stock sale

BeOne Medicines Ltd. officer Titus Benjamin Ball reported a proposed sale of 1,559 ADS on November 6, 2026, with an aggregate market value of $632,277.24; the sale is listed for NASDAQ.

Available on EDGAR 11/06/2026 - 05:12 PM EST Accepted by SEC EDGAR 11/06/2026 - 05:11 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

BeOne Medicines Ltd. officer Titus Benjamin Ball reported a proposed sale of 1,559 ADS on November 6, 2026, with an aggregate market value of $632,277.24; the sale is listed for NASDAQ. The ADS are described as acquired through exercise of options under a registered plan, with cash listed as the payment method. Ball also reported selling 132 ADS on September 1, 2026, with an aggregate market value of $46,973.52.

Key Figures

Proposed sale: 1,559 ADS Aggregate market value of proposed sale: $632,277.24 ADS outstanding: 58,926,111 ADS +2 more

5 metrics

Proposed sale 1,559 ADS Proposed for November 6, 2026

Aggregate market value of proposed sale $632,277.24 Proposed sale for November 6, 2026

ADS outstanding 58,926,111 ADS Number of ADS outstanding

Prior sale 132 ADS Sold September 1, 2026

Aggregate market value of prior sale $46,973.52 132 ADS sold September 1, 2026

Key Terms

ADS, Rule 144, Exercise of Options Under a Registered Plan

3 terms

ADS technical

"ADS"

Ads are paid promotional messages a company places across media — online, on TV, in print, or on social platforms — to attract customers, explain products, or shape public perception. For investors, ads matter because they drive sales growth, affect how much a company must spend to win customers, and influence brand strength and long-term value. Ads can also create regulatory or reputational risk if claims are misleading, which can affect profits and stock price.

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Exercise of Options Under a Registered Plan financial

"Exercise of Options Under a Registered Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ONC ADS did Titus Benjamin Ball propose to sell?

Titus Benjamin Ball reported a proposed sale of 1,559 ADS, with an aggregate market value of $632,277.24, for November 6, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001675628
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BeOne Medicines Ltd.
SEC File Number	001-37686
Address of Issuer	94 Solaris Avenue, Camana Bay Grand Cayman CAYMAN ISLANDS KY1 1108
Phone	345-949-4123
Name of Person for Whose Account the Securities are To Be Sold	TITUS BENJAMIN BALL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ADS	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1559	632277.24	58926111	11/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ADS	11/06/2026	Exercise of Options Under a Registered Plan	Issuer			1559	11/06/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
TITUS BENJAMIN BALL 94 Solaris Avenue, Camana Bay Grand Cayman E9 KY1 1108	ADS	09/01/2026	132	46973.52

144: Remarks and Signature

Remarks
Date of Notice	11/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Titus B. Ball
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)